Cipla Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:	500087	NSE Symbol:	CIPLA	P/E :	26.74
ISIN Demat:	INE059A01026	Div & Yield %:	0.84	EPS :	57.63
Book Value:	360.73	Market Cap (Rs. Cr.):	124,457.39	Face Value :	2

Date	Headline
17-Apr-25	Cipla allots 23,282 equity shares under ESOS
11-Apr-25	Cipla receives USFDA approval for Protein-bound Paclitaxel for Injectable Suspension
08-Apr-25	Cipla to table results
08-Feb-25	USFDA classifies cGMP inspection of Cipla's Virgonagar facility as VAI
03-Feb-25	Cipla to infuse ZAR 900 million in Cipla Medpro South Africa Proprietary Limited
07-Jan-25	Cipla to table results
15-Nov-24	Cipla allots 17,064 equity shares under ESOS
25-Oct-24	Cipla completes acquisition of additional 6.9% stake in Cipla Jiangsu
03-Oct-24	Cipla to table results
25-Sep-24	Cipla to acquire JV partners' 6.91% in Cipla Jiangsu

Company Snapshot